AMP 2025
One-Year Outcomes of Drug-Eluting Stent vs Drug-Coated Balloon for Femoropopliteal Artery Lesions: The BEASTARS Study Results
10/08/2025
In this video recorded at AMP 2025, interventional cardiologist Tatsuya Nakama, MD, from Tokyo Bay Medical Center in Urayasu, Japan, discusses his AMP presentation on 1-year results from the BEASTARS study. The BEASTARS study aims to compare the clinical outcomes of drug-eluting stents and drug-coated balloons in patients with symptomatic femoropopliteal artery disease.
About Us
Vascular Disease Management™ (VDM), the official media partner of the International Symposium on Endovascular Therapy (ISET) and the Amputation Prevention Symposium (AMP), is a peer-reviewed journal that educates readers on the latest advancements in endovascular treatment strategies.
Learn more about ISET and AMP and register for the events here:
Subscribe Now!
Vascular Disease Management Newsletter




